PT  - JOURNAL ARTICLE
AU  - Davide Elia
AU  - Antonella Caminati
AU  - Maurizio Zompatori
AU  - Roberto Cassandro
AU  - Chiara Lonati
AU  - Francesca Luisi
AU  - Giuseppe Pelosi
AU  - Steeve Provencher
AU  - Sergio Harari
TI  - Pulmonary hypertension and chronic lung disease: where are we headed?
AID  - 10.1183/16000617.0065-2019
DP  - 2019 Sep 30
TA  - European Respiratory Review
PG  - 190065
VI  - 28
IP  - 153
4099  - http://err.ersjournals.com/content/28/153/190065.short
4100  - http://err.ersjournals.com/content/28/153/190065.full
SO  - EUROPEAN RESPIRATORY REVIEW2019 Sep 30; 28
AB  - Pulmonary hypertension related to chronic lung disease, mainly represented by COPD and idiopathic pulmonary fibrosis, is associated with a worse outcome when compared with patients only affected by parenchymal lung disease. At present, no therapies are available to reverse or slow down the pathological process of this condition and most of the clinical trials conducted to date have had no clinically significant impact. Nevertheless, the importance of chronic lung diseases is always more widely recognised and, along with its increasing incidence, associated pulmonary hypertension is also expected to be growing in frequency and as a health burden worldwide. Therefore, it is desirable to develop useful and reliable tools to obtain an early diagnosis and to monitor and follow-up this condition, while new insights in the therapeutic approach are explored.New prospective in the management of pulmonary hypertension related to chronic lung diseases http://bit.ly/2lW4CfE